Our facilities has been approved by WHO-GMP and several international regulators across the semi-regulated markets. It caters to the bulk of the demand for solid orals, liquid orals, and external creams and powders across markets in Asia, Africa, Middle East, Russia and Latin America.
Test Equipment and Facilities : The manufacturing facilities are based in Mehsana, (Gujarat), Baroda, Sarigam (Daman and Diu) and Raigad (Puna Expressway, Maharashtra) and operated by Taj Pharmaceuticals Ltd.
In our quest to be the leading manufacturer in the pharmaceutical industry and a Generics player of global standing; we aspire to meet and excel the highest industry standards. To this end, on the manufacturing front, we have designed and engineered our production facilities to the most rigorous benchmarks and according to the guidelines of world health organisation.
We operate with modern facility for the production of sterile powder formulations, non-sterile oral formulations and active pharmaceutical ingredients.
Some other features of our facility:
* Modern QA, QC, Microbiological and PD Lab supported with high-tech equipment.
The Hyderabad plant is the ONLY plant in the world producing all the effective ranges of Anti-tuberculosis formulations namely Ethambutol Hydrochloride (B.P.), Rifampicin (B.P.), Isoniazid (B.P.), Pyrazinamide (B.P.), Rifampicin-Isoniazid (B.P.), Rifampicin-Isoniazid-Pyrazinamide (B.P.), Ethionamide (B.P.) and Prothionamide (B.P.) – all in Tablet form. Production of bulk actives such as Ethambutol, Rifampicin and Pyrazinamide are also undertaken at Valsad, Gujrat (India).
R D activity is a continuous on-going process and the R D Division at all Units and has been duly approved by the Department of Scientific and Industrial Research, (DSIR), Government of India.